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A 72-year-old Caucasian malewho presented with haematuria in July of 2000was found to have a large left-sided bladder tumour.
He underwent a transurethral resection of the tumour and surveillance program. In October 2008 he underwent a transurethral
resection of the prostate (TURP). Histology of the prostatic chippings showed poorly diﬀerentiated TCC with prostatic invasion.
A CT of his chest abdomen and pelvis revealed no lymph node involvement or metastatic spread. He therefore underwent a
cystoprostato-urethrectomy with ileal conduit formation,in December 2008. In May 2010the decision was made to perform a left
inguinal orchidectomy as he presented with a craggy massof his left testis, and there were clinical concerns thatthis was a tumour.
Histology revealed that the left testis had been wholly replaced by a tumour. Taking into account his previous urological history,
the features of this tumour are consistent with metastatic TCC, which is very rare.
1.CaseReport
A 72-year-old Caucasian male who presented with haema-
turia in July of 2000 was found to have a large left-sided
bladdertumour, and urine cytologyrevealed malignant cells.
A renal ultrasound scan (USS) at the time was normal.
Transurethral resection of the tumour (TURBT) showed a
G2 pT1 transitional cell carcinoma (TCC) of the bladder.
A check cystoscopy in 2002 revealed a red patch over the
previous resection site; and biopsies revealed transitional
cell carcinoma in situ (Tis) which was managed by a six-
week course of intravesical BCG. He continued cystoscopic
surveillance, unfortunately in March 2005 further cysto-
scopic biopsies again revealed transitional cell carcinoma
in situ (Tis), this was managed by further instillations
of intravesical BCG. He again underwent a surveillance
cystoscopy programme with biopsies when indicated, which
were unremarkable until June 2008, where biopsies showed
a reoccurrence of Tis again managed by six-week course of
intravesical BCG.
In October 2008 he underwent a transurethral resection
o ft h ep r o s t a t e( T U R P )a sh eh a dp r e s e n t e dw i t ha c u t e
retention of urine. Histology of the prostatic chippings
showed poorly diﬀerentiated TCC with prostatic invasion. A
CT of his chest abdomen and pelvis revealed no lymph node
involvement or metastatic spread. He therefore underwent a
cystoprostato-urethrectomy with ileal conduit formation, in
December 2008. Surveillance CT scans (including urogram
phases) in June and November 2009 were unremarkable.
He presented to the urology department in January
2010 complaining of a 2-week history of left testicular pain.
Examination was unremarkable, but a scrotal USS suggested
epididymo-orchitis as a potential diagnosis; thus, a 2-week
course of ciproﬂoxacin (500mg twice daily) was prescribed
and his symptoms improved. However his pain never really
settled but he did not represent until May 2010. On this
occasionexamination revealedacraggymass andgeneralised
scrotal swelling. A scrotal USS revealed an enlarged testis
with hypervascularity compatible with orchitis (Figure 1).
The decision was made to perform a left inguinal
orchidectomy to clinical concerns that this was a tumour.
Histology revealed that the left testis had been wholly
replaced by a tumour composed of islands of pleomorphic
cells with surrounding desmoplastic stroma and the ghost
outlines of atrophic seminiferous tubules. Immunohisto-
chemical studies showed the tumour to be strongly positive2 Advances in Urology
Figure 1: A scrotal USS revealed an enlarged testis with hypervas-
cularity compatible with orchitis, May 2010.
Figure 2: Above: CT scan June 2010 revealing abdominal para-
aorticlymphadenopathy. Below:unremarkable CT scan,November
2009.
for AE1/AE3and CK7, whilst it was focally positive for CK20
and negative for PLAP, PSA, CEA and vimentin. Taking into
account his previous urological history, the features of this
tumour are consistent with metastatic TCC.
Urgent CT and bone scans were arranged (June 2010).
The bone scan was unremarkable; unfortunately CT revealed
abdominal para-aortic lymphadenopathy which is new since
the CT in November 2009 and almost certainly due to
f urth erm eta s ta s es(Fi gur e2:acomparisonbetween CTscans
in November 2009 and June 2010). He is now about to
commence chemotherapy.
2.Discussion
Testicular metastasis from bladder TCC is very rare. Fol-
lowing a comprehensive literature search, there have been
8 reported cases from 1984 to 2006, to the best of our
knowledge. Three cases have been from the UK [1–3].
ClassicallythemodeofspreadofTCCisdirect,implanta-
tion, lymphatic, and haematogenous. Direct spread involves
tumour growth into detrusor muscle, the ureters, prostate,
urethra, uterus, vagina, perivesical fat, bowel, and pelvic
side walls. Implantation may be into wounds and percu-
taneous catheter tracts. Lymphatic inﬁltration is usually
to the iliac and para-aortic nodes. Haematogenous spread
commonlyinvolvestheliver(38%),lung(36%),bone(27%),
and adrenal glands (21%). It is important to note that
haematogenous spread may involve any organ [4].
There are a number of important learning points from
this case. This gentleman presented with Tis in 2002, 2005
and 2008, which seemed to respond to BCG each time it
was reinstigated, and perhaps a radical cystectomy should
have been performed at this point as recommended by the
European Association of Urology (EAU) [5]. Also, when
the patient presented in January 2010 with left testicular
pain he was treated for an infection, although his symptoms
improved with antibiotics, should a more open mind have
been keptin view of the symptoms not resolving completely?
In addition to this he was not seen again after this episode
for approximately 4 months due to more than one hospital
looking after him.
A key learning point is the fact that metastatic disease
to the testis was never considered as a diagnosis until the
histology was obtained from orchidectomy; however, this is
understandable due to its rarity. Also, as this man no longer
hadabladder,thereforeheisunlikelytodevelopepididymitis
secondary to urosepsis.
In conclusion a diagnosis of metastatic transitional cell
carcinoma of the bladder presenting at any site must be
considered in all men with bladder neoplasia.
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